Peptides and methods for reducing skin pigmentation
US-2024190917-A1 · Jun 13, 2024 · US
Compositions and methods for inhibiting terminal transferase activity
US9752173B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9752173-B2 |
| Application number | US-201514754262-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 29, 2015 |
| Priority date | Apr 8, 2010 |
| Publication date | Sep 5, 2017 |
| Grant date | Sep 5, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention realtes to systems and methods for amplifying nucleic acid. In particular, systems and methods are provided for inhibiting polymerase based terminal transferase activity within a polynucleotide amplification setting (e.g., polymerase chain reaction). In addition, systems and methods are provided for generating amplified products generated with polynucleotide amplification techniques having reduced 3′ non-templated nucleotide addition.
First claim
Opening claim text (preview).
We claim: 1. A kit comprising a PCR reaction solution, wherein said PCR reaction solution comprises boric acid, deoxynucleotide triphosphates, divalent cations, KCl and Tris-HCl or (NH) 4 SO 4 and Tris-HCl, and a polymerase having terminal transferase activity. 2. The kit of claim 1 , wherein said divalent cations are selected from group consisting of Mg 2+ and Mn 2+ divalent cations. 3. The kit of claim 1 , wherein said polymerase having terminal transferase activity is Taq polymerase or a fragment thereof.
Assignees
Inventors
Classifications
Terminal transferase · CPC title
being a mass spectrometer · CPC title
Specific component of sample, medium or buffer · CPC title
IL-4 · CPC title
- C07K14/4703Primary
Inhibitors; Suppressors · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9752173B2 cover?
- The present invention realtes to systems and methods for amplifying nucleic acid. In particular, systems and methods are provided for inhibiting polymerase based terminal transferase activity within a polynucleotide amplification setting (e.g., polymerase chain reaction). In addition, systems and methods are provided for generating amplified products generated with polynucleotide amplification …
- Who is the assignee on this patent?
- Ibis Biosciences Inc, Hofstadler Nina M
- What technology area does this patent fall under?
- Primary CPC classification C07K14/4703. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).